figshare
Browse
DATASET
Source data file.xlsx (178.45 kB)
ARCHIVE
TCRb CDR3.zip (4.72 MB)
1/0
2 files

Source data file.xlsx

Download all (4.89 MB)
Version 2 2024-05-03, 20:39
Version 1 2024-05-03, 19:13
journal contribution
posted on 2024-05-03, 20:39 authored by Anders HansenAnders Hansen

An in situ depot for the sustained release of a TLR7/8 agonist in combination with a TGFβ inhibitor promotes anti-tumor immune responses. Manuscript source data for figures

TCRb CDR3 immune sequencing. CC: CarboCell TLR:TGFb, UT: untreated control


History

Usage metrics

    Categories

    Keywords

    Oncologyintratumor injectionTLR7/8 agonistsTGF -β activation inhibitiondepot technologyTCRb CDR3 sequence data

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC